Brandywine Global Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58M | Sell |
|
|||||
|
2025
Q1 | $58.5M | Sell |
|
|||||
|
2024
Q4 | $54M | Sell |
|
|||||
|
2024
Q3 | $62.8M | Buy |
|
|||||
|
2024
Q2 | $61.6M | Sell |
|
|||||
|
2024
Q1 | $71.3M | Buy |
|
|||||
|
2023
Q4 | $58M | Buy |
|
|||||
|
2023
Q3 | $52.3M | Sell |
|
|||||
|
2023
Q2 | $53.3M | Buy |
|
|||||
|
2023
Q1 | $48.5M | Sell |
|
|||||
|
2022
Q4 | $49.9M | Buy |
|
|||||
|
2022
Q3 | $37M | Buy |
|
|||||
|
2022
Q2 | $57M | Sell |
|
|||||
|
2022
Q1 | $58.4M | Sell |
|
|||||
|
2021
Q4 | $60.8M | Buy |
|
|||||
|
2021
Q3 | $45.1M | Buy |
|
|||||
|
2021
Q2 | $39.9M | Buy |
|
|||||
|
2021
Q1 | $28.6M | Buy |
|
|||||
|
2020
Q4 | $27.5M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $67.9M | Sell |
|
|||||
|
2013
Q3 | $64.4M | Sell |
|
|||||
|
2013
Q2 | $65.2M | Buy |
|